COSMOS Pharmaceutical Corporation
CSMYF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $57 | $23 | $39 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $12 | $1 | $1 |
| Inventory | $1 | $92 | $88 | $94 |
| Other Curr. Assets | $0 | $1 | $15 | $16 |
| Total Curr. Assets | $1 | $166 | $127 | $150 |
| Property Plant & Equip (Net) | $2 | $348 | $320 | $326 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $26 |
| Tax Assets | $0 | $3 | $0 | $0 |
| Other NC Assets | $0 | $8 | $27 | -$17 |
| Total NC Assets | $2 | $359 | $347 | $337 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4 | $525 | $474 | $487 |
| Liabilities | – | – | – | – |
| Payables | $1 | $177 | $157 | $174 |
| Short-Term Debt | $0 | $6 | $8 | $4 |
| Tax Payable | $0 | $12 | $0 | $8 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $12 | $31 | $27 |
| Total Curr. Liab. | $1 | $221 | $196 | $213 |
| LT Debt | $0 | $37 | $21 | $21 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $5 | $9 | $9 |
| Total NC Liab. | $0 | $47 | $30 | $30 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $7 | $0 | $0 |
| Total Liabilities | $2 | $267 | $225 | $243 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $4 | $4 | $4 |
| Retained Earnings | $2 | $248 | $240 | $234 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $2 | $257 | $249 | $243 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4 | $525 | $474 | $487 |
| Net Debt | -$0 | -$14 | $6 | -$13 |